• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Design Your Healthy and Happy Life With 3 Quick Makeovers: Small Steps Equal a Big Impact
Design your healthy and happy life with these super quick makeover tips that will have you wanting more. A healthy and happy life is about living blissfully, with passion and purpose, not just about the absence of disease. The great news is that we can design our own healthy lifestyle plan just like interior designers create beautiful spaces; we can design it no matter where we are in your own health journey; dealing with an illness, or recovering from an injury. What's even better news is that we don't need to do a complete overhaul. Who doesn't love a quick makeover? Sometimes, all it takes is new throw pillows or a bold...
Source: Healthy Living - The Huffington Post - September 29, 2015 Category: Consumer Health News Source Type: news

A Compilation of Spasticity Studies Evaluating Onabotulinumtoxin A (P3.042)
CONCLUSIONS: OnabotulinumtoxinA has been extensively studied for treatment of spasticity against a variety of rating scales/assessments and outcomes measures.Study Sponsored by: Allergan, Inc.Disclosure: Dr. Patel has received personal compensation for activities with Allergan Inc. Dr. Manack has received personal compensation for activities with Allergan Inc.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Patel, P., Manack, A. Tags: Neural Repair and Neuro-rehabilitation: Clinical Source Type: research

OnabotulinumtoxinA in Lower Limb Spasticity: Safety Results from a Pooled Analysis (P03.266)
CONCLUSIONS: OnabotulinumtoxinA treatment in lower limb spasticity was found to be safe and well-tolerated. Majority of AEs were considered not related to onabotulinumtoxinA and treatment-related AEs are consistent with the known mechanism of action of onabotulinumtoxinA.Supported by: Allergan, Inc.Disclosure: Dr. Earl has received personal compensation for activities with Allergan, Inc. as an employee. Dr. Earl holds stock and/or stock options in AGN and GlaxoSmithKline, Inc. Dr. James has received personal compensation for activities with Allergan, Inc as an employee. Dr. Li has received personal compensation for activit...
Source: Neurology - February 14, 2013 Category: Neurology Authors: Earl, N., James, L., Li, H.-I., Shi, G., Demos, G., Dimitrova, R. Tags: P03 Neural Repair Source Type: research

Classifying Patients with Spatial Neglect by "Aiming" Versus "Where" Spatial Bias May Explain Differential Response to Bromocriptine Treatment (P03.261)
CONCLUSIONS: Classifying spatial neglect may be vital to interpreting rehabilitation outcomes and treatment studies. In this group study, larger than those performed previously, patients with "aiming" bias appeared to respond favorably to bromocriptine. However, "aiming" neglect patients may also have had milder neglect than those with "where" bias. Therefore, identifying "aiming" bias may also identify milder forms of neglect likely to respond to bromocriptine. Future studies with more bias-characterized patients are indicated.Disclosure: Dr. Chaudhari has nothing to disclose. Dr. Shah has nothing to disclose. Dr. Goedert...
Source: Neurology - February 14, 2013 Category: Neurology Authors: Chaudhari, A., Shah, P., Goedert, K., Adler, U., Barrett, A. Tags: P03 Neural Repair Source Type: research

OnabotulinumtoxinA Efficacy in Lower Limb Spasticity: Results of Three Studies (P03.264)
CONCLUSIONS: OnabotulinumtoxinA (300U) significantly decreases ankle flexor tone in adults with post-stroke lower-limb spasticity.Supported by: Allergan, Inc.Disclosure: Dr. Dimitrova has received personal compensation for activities with Allergan, Inc. as an employee. Consulting service from Glaxo-Smith-Kline, Japan.....Financial support from GSK Japan, Eisai Dr. Kaji has received personal compensatino for activities with Glaxo-Smith-Kline, Japan as a consultant. Dr. Kaji has received research support from GSK Japan, Eisai. Dr. Ward has received personal compensation for activities with Allergan Inc. as a participant on a...
Source: Neurology - February 14, 2013 Category: Neurology Authors: Dimitrova, R., Kaji, R., Ward, A., Li, H.-I., Fulford-Smith, A., Earl, N. Tags: P03 Neural Repair Source Type: research